CMS holds off on Medicaid price data
CMS will not publicly release current average manufacturer prices(AMP) slated to be used to calculate Medicaid reimbursement ongenerics, according to administrator Mark McClellan. With inputfrom pharmacy, the agency has concluded that the definition of AMPmust be revised to reflect the prices retail pharmacies actuallypay for generics.
CMS will not publicly release current average manufacturer prices (AMP) slated to be used to calculate Medicaid reimbursement on generics, according to administrator Mark McClellan. With input from pharmacy, the agency has concluded that the definition of AMP must be revised to reflect the prices retail pharmacies actually pay for generics. A proposed rule on the new definition will be open for public comment later this year, he told attendees at NCPA's annual legislative and government conference.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
Lean Six Sigma: Helping Long-Term Care Pharmacies Thrive in a Challenging Market
April 15th 2024Long-Term Care (LTC) pharmacies are playing a critical role in delivering care primarily for our aging population. Yet LTC pharmacies face many challenges, including rising costs, space constraints, labor availability and many others.
